X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9081) 9081
Publication (1237) 1237
Newspaper Article (185) 185
Book Review (104) 104
Book Chapter (74) 74
Newsletter (57) 57
Book / eBook (34) 34
Conference Proceeding (14) 14
Transcript (4) 4
Dissertation (3) 3
Data Set (2) 2
Web Resource (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7027) 7027
index medicus (5688) 5688
female (2977) 2977
male (2904) 2904
immunology (2524) 2524
animals (2417) 2417
antigens (2352) 2352
middle aged (2075) 2075
lymphocytes (2019) 2019
adult (1883) 1883
oncology (1849) 1849
cancer (1773) 1773
hematology (1650) 1650
aged (1628) 1628
immunotherapy (1483) 1483
t cells (1423) 1423
lymphomas (1359) 1359
mice (1352) 1352
pathology (1317) 1317
expression (1313) 1313
flow cytometry (1283) 1283
lymphocytes t (1130) 1130
research (1124) 1124
immunohistochemistry (1110) 1110
lymphocytes b (1087) 1087
b-lymphocytes - immunology (1068) 1068
tumors (1043) 1043
immunoglobulins (1030) 1030
analysis (1011) 1011
health aspects (1005) 1005
gene expression (975) 975
leukemia (959) 959
b cells (954) 954
rituximab (952) 952
proteins (951) 951
medicine (939) 939
care and treatment (920) 920
antibodies (894) 894
research article (884) 884
immune system (881) 881
patients (848) 848
lymphoma (846) 846
immunophenotyping (837) 837
cell biology (824) 824
multidisciplinary sciences (817) 817
dendritic cells (807) 807
cytokines (796) 796
disease (775) 775
chemotherapy (769) 769
medicine, research & experimental (740) 740
article (739) 739
science (726) 726
t-lymphocytes - immunology (724) 724
genetic aspects (721) 721
aged, 80 and over (713) 713
adolescent (686) 686
apoptosis (686) 686
t-cells (669) 669
prognosis (667) 667
monoclonal antibodies (665) 665
medical research (646) 646
transplantation (638) 638
cytotoxicity (635) 635
diagnosis (627) 627
therapy (620) 620
activation (596) 596
t cell receptors (592) 592
cd20 antigen (580) 580
immune response (564) 564
child (563) 563
inflammation (553) 553
hemic and lymphatic diseases (547) 547
mutation (536) 536
bone marrow (531) 531
cell line, tumor (518) 518
antibodies, monoclonal - therapeutic use (516) 516
stem cells (516) 516
medicine & public health (504) 504
antigen (500) 500
autoimmunity (500) 500
biology (492) 492
young adult (481) 481
treatment outcome (478) 478
physiological aspects (477) 477
b-lymphocytes - metabolism (476) 476
antigens, cd20 - immunology (470) 470
in-vivo (465) 465
development and progression (461) 461
infections (460) 460
pathogenesis (459) 459
clinical trials (455) 455
polymerase chain reaction (455) 455
review (452) 452
cells (450) 450
cd4 antigen (447) 447
survival (442) 442
phenotype (440) 440
biopsy (437) 437
immunity (434) 434
signal transduction (432) 432
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (21) 21
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Trinity College (John W Graham) - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Toronto East General Hospital - Stacks (2) 2
Humber River Regional Hospital - Church Stacks (1) 1
Online Resources - Online (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9341) 9341
Chinese (72) 72
Japanese (29) 29
French (8) 8
Russian (7) 7
German (6) 6
Spanish (6) 6
Portuguese (3) 3
Hungarian (2) 2
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 06/2010, Volume 115, Issue 22, pp. 4393 - 4402
Journal Article
The Journal of Immunology, ISSN 0022-1767, 07/2006, Volume 177, Issue 1, pp. 362 - 371
Journal Article
Clinical & Experimental Immunology, ISSN 0009-9104, 06/2016, Volume 184, Issue 3, pp. 284 - 292
Summary Compelling evidence suggests that interleukin (IL)‐17 and IL‐17‐producing cells play a pivotal role in the pathogenesis of primary Sjögren's syndrome... 
salivary glands | Sjögren's syndrome | rituximab | Th17 cells | Rituximab | Salivary glands | Sjogren's syndrome | ANTI-CD20 ANTIBODY | 17 CELL SUBSETS | PERIPHERAL-BLOOD | IMMUNOLOGY | SALIVARY-GLANDS | MOUSE MODEL | SYNDROME SIMILARITIES | UPDATE | EXPRESSION | SYNDROME ASSOCIATION | Salivary Glands - immunology | Salivary Glands - pathology | Humans | Middle Aged | Interleukin-17 - immunology | Sjogren's Syndrome - immunology | Adrenal Cortex Hormones - therapeutic use | Dexamethasone - analogs & derivatives | Rituximab - therapeutic use | Th17 Cells - drug effects | CD3 Complex - genetics | Adult | Female | Salivary Glands - drug effects | Sjogren's Syndrome - genetics | CD4 Antigens - genetics | Th17 Cells - pathology | Antigens, CD20 - immunology | CD4 Antigens - immunology | Gene Expression | Sjogren's Syndrome - pathology | Sjogren's Syndrome - drug therapy | Interleukin-17 - genetics | CD8 Antigens - immunology | Antigens, CD20 - genetics | Dexamethasone - therapeutic use | Pilot Projects | CD3 Complex - immunology | CD8 Antigens - genetics | Th17 Cells - immunology | Primary Cell Culture | Immunologic Factors - therapeutic use | Viral antibodies | Antimitotic agents | Medical research | Corticosteroids | Interleukins | Analysis | Medicine, Experimental | Antibodies | T cells | Antineoplastic agents | Original
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 9/2018, Volume 171, Issue 2, pp. 273 - 282
The purpose of the study was to evaluate protein expression of PD-L1 and CD20 as prognostic biomarkers of patient outcome in inflammatory breast cancer (IBC)... 
CD20 | Medicine & Public Health | Patient outcome | PD-L1 | Inflammatory breast cancer | Triple-negative | Oncology | Immuno-oncology | SURVIVAL | PREDICTS | PDL1 EXPRESSION | ANTIBODY | LIGAND 1 PD-L1 | TRENDS | CHEMOTHERAPY | ONCOLOGY | SURVEILLANCE | CARCINOMA | EPIDEMIOLOGY | Immunohistochemistry | Prognosis | Inflammatory Breast Neoplasms - pathology | Humans | Triple Negative Breast Neoplasms - immunology | Inflammatory Breast Neoplasms - metabolism | Triple Negative Breast Neoplasms - pathology | Female | Lymphocytes, Tumor-Infiltrating - metabolism | B-Lymphocytes - pathology | B-Lymphocytes - metabolism | Gene Expression | Kaplan-Meier Estimate | Programmed Cell Death 1 Receptor - metabolism | Triple Negative Breast Neoplasms - mortality | Antigens, CD20 - metabolism | B7-H1 Antigen - genetics | Antigens, CD20 - genetics | B7-H1 Antigen - metabolism | B-Lymphocytes - immunology | Lymphocytes, Tumor-Infiltrating - pathology | Triple Negative Breast Neoplasms - metabolism | Biomarkers | Inflammatory Breast Neoplasms - immunology | Inflammatory Breast Neoplasms - mortality | Lymphocytes, Tumor-Infiltrating - immunology | Patient outcomes | Analysis | Oncology, Experimental | Immunotherapy | Breast cancer | B cells | Research | Cancer | inflammatory breast cancer | immuno-oncology | triple-negative | patient outcome
Journal Article
Blood, ISSN 0006-4971, 10/2017, Volume 130, Issue 14, pp. 1628 - 1638
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2016, Volume 22, Issue 1, pp. 86 - 95
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 04/2015, Volume 29, Issue 4, pp. 947 - 957
The long-lasting clinical response by lymphoma patients to anti-CD20 therapy has been attributed to the induction of an anti-tumor adaptive immunity. We... 
ADAPTIVE IMMUNITY | EFFECTOR | ONCOLOGY | IMMUNOTHERAPY | RITUXIMAB | IN-VIVO | INNATE | LYMPHOMA | MONOCLONAL-ANTIBODIES | HEMATOLOGY | CANCER | TUMOR-IMMUNITY | Forkhead Transcription Factors - immunology | Th1 Cells - pathology | Lymph Nodes - pathology | Interleukin-12 - genetics | Th2 Cells - immunology | Th1 Cells - immunology | Th2 Cells - drug effects | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Th17 Cells - drug effects | Lymphoma, B-Cell - immunology | Female | Lymph Nodes - drug effects | Antineoplastic Agents - pharmacology | Interferon-gamma - genetics | Th2 Cells - pathology | CD4 Antigens - genetics | Lymphoma, B-Cell - drug therapy | Th17 Cells - pathology | CD4 Antigens - immunology | Th1 Cells - drug effects | Lymphoma, B-Cell - mortality | Signal Transduction | Mice, Inbred C57BL | Rituximab | Gene Expression Regulation, Leukemic | Lymph Nodes - immunology | Forkhead Transcription Factors - genetics | T-Lymphocytes, Regulatory - drug effects | Adaptive Immunity - drug effects | Animals | Interferon-gamma - immunology | Interleukin-12 - immunology | Lymphoma, B-Cell - pathology | Survival Analysis | Th17 Cells - immunology | Immunologic Memory | Cell Proliferation - drug effects | Mice | Antibodies, Monoclonal, Murine-Derived - pharmacology | Therapy | Change detection | Interleukin | Helper cells | Effector cells | Lymphocytes T | Immunity | Lymph nodes | Lymphocytes | Foxp3 protein | Expansion | Spleen | Immunological memory | Memory cells | Cell survival | Cytokines | Dendritic cells | Immunoregulation | Tumor cells | Interleukin 12 | Adaptive immunity | Survival | Lymphoma | CD4 antigen | Depletion | γ-Interferon | CD20 antigen | Interferon
Journal Article